Latest Breaking News On - Inhibrx daily - Page 1 : vimarsana.com

Insider Selling: Inhibrx, Inc (NASDAQ:INBX) Insider Sells 300,000 Shares of Stock

Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) insider Brendan P. Eckelman sold 300,000 shares of the business’s stock in a transaction dated Tuesday, May 28th. The shares were sold at an average price of $34.30, for a total value of $10,290,000.00. Following the sale, the insider now directly owns 1,735,553 shares of the company’s stock, […]

United statesBrendanp eckelmanSecurities exchange commissionChina universal asset management coInhibrx incInhibrx company profileQuadrant capital groupGet free reportExchange commissionCapital groupUniversal asset managementArizona state retirement systemInhibrx daily

Inhibrx (NASDAQ:INBX) Sees Large Volume Increase

Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) shares saw an uptick in trading volume on Wednesday . 764,772 shares traded hands during trading, an increase of 19% from the previous session’s volume of 644,035 shares.The stock last traded at $34.26 and had previously closed at $34.14. Analyst Upgrades and Downgrades A number of brokerages have […]

Inhibrx company profileInhibrx incHennion walsh asset management incPricet rowe associates incQuadrant capital groupGet free reportCapital groupWalsh asset managementPricet rowe associatesInhibrx daily

Inhibrx (NASDAQ:INBX) Sees Unusually-High Trading Volume

Shares of Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) saw an uptick in trading volume on Monday . 1,719,541 shares were traded during trading, an increase of 139% from the previous session’s volume of 718,804 shares.The stock last traded at $34.92 and had previously closed at $34.97. Analyst Upgrades and Downgrades INBX has been the […]

Hong kongQuadrant capital groupHong kong ltdInhibrx incGet free reportCapital groupKong ltdInhibrx dailyNasdaq inbx

Contrasting Inhibrx (NASDAQ:INBX) & Novavax (NASDAQ:NVAX)

Inhibrx (NASDAQ:INBX – Get Free Report) and Novavax (NASDAQ:NVAX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, risk, earnings, profitability, valuation, dividends and institutional ownership. Analyst Ratings This is a summary of current ratings […]

United statesLa jollaChiesi farmaceuticiBristol myers squibb companyNovavax incInhibrx incGet free reportGiven novavaxInhibrx daily

Inhibrx (NASDAQ:INBX) Reaches New 1-Year High at $39 79

Inhibrx (NASDAQ:INBX) Reaches New 1-Year High at $39 79
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Inhibrx incInhibrx company profilePerceptive advisorsBlackrock incVanguard group incGet free reportStreet corpVanguard groupInhibrx daily